Scintica, a leading value-added reseller of advanced preclinical research instrumentation, is excited to announce a new collaboration with Bioemtech, dedicated to desktop SPECT, PET, and Optical scanners for use in preclinical research. The partnership aims to expand the availability of our preclinical instruments to research scientists around the world. Under the agreement, Scintica will become the global distributor of our innovative preclinical molecular imaging systems. This collaboration will enable researchers to access a range of state-of-the-art imaging systems for in vivo screening of SPECT and PET isotopes, as well as enable seamless integration with Optical imaging with fluorescence, bioluminescence, and Cherenkov luminescence. “We are excited to partner with Bioemtech to bring their innovative preclinical imaging systems to researchers around the world,” said Blair Poetschke, President of Scintica. “Our team of scientists is committed to providing researchers with the training and support they need to get the most out of these advanced research tools.” The collaboration between Scintica and Bioemtech will help drive advancements in the preclinical research field by providing researchers with the tools they need to conduct cutting-edge research. Bioemtech’s CEO, George Loudos, added, “We are very enthusiastic to partner with Scintica, whose global distribution channel will allow our technology to be properly demonstrated and communicated worldwide. We also feel proud that Scintica, having strong scientific expertise and market experience, appreciated BIOEMTECH technology and believes as we do that it will facilitate the daily work of numerous researchers worldwide”. The “eyes” family of scanners is a new imaging concept for real-time, in vivo, screening of tracers, all available as high-resolution, benchtop scanners. The eye-series offers 3 scanners for integrated in vivo imaging: γ-eye – imaging system for all SPECT isotopes, β-eye – imaging system for real-time PET isotopes screening and the φ-eye – in vivo optical imaging system for preclinical studies. Scintica is a value-added reseller of advanced preclinical research instrumentation with offices in Canada, the USA, and Europe, as well as a network of support across most of the world. Scintica carries a diverse but synergistic portfolio of products, encouraging a holistic approach to science, ranging from imaging systems to laboratory tools and equipment for both in vitro and in vivo studies.

0

0